Study and year | Sample size | Treatment approach | Treatment schedule | 3 y or 5 y OS (CRT V. CT + S) |
---|---|---|---|---|
Stahl, [33] | 119 | CRT-Surgery V. CT-Surgery | Scheme of CRT: GTV30Gy/15f cisplatin (50Â mg/m2), etoposide (80Â mg/m2) | 3y: 52% V. 49% |
Scheme of CT: 5-Fu (2Â g/m2) leucovorin (500Â mg/m2) cisplatin (50Â mg/m2) | 5y: 45% V. 36% | |||
Burmeister, [32] | 75 | CRT-Surgery V. CT-Surgery | Scheme of CRT: Cisplatin (80Â mg/m2) 5-Fu (1000Â mg/m2/d) GTV35Gy/15f | 3y: 47.4% V. 27.7% |
5y: NM | ||||
Scheme of CT: Cisplatin(80Â mg/m2) 5-Fu (1000Â mg/m2/d) |